European Companies Search Engine

EU funding (€11M): Integrated and standardized NGS workflows for Personalised therapy Hor1 Jan 2020 EU Research and Innovation programme "Horizon"

Text

Integrated and standardized NGS workflows for Personalised therapy

Instand-NGS4P is a 65-month PCP project federating 7 leading medical centers (two are coordinating ERNs) as buyers’ group with major experience in using different NGS platforms in research and routine diagnostics. The consortium is further strengthened by European patient advocacy groups, a standardization organization and partners participating in the European infrastructures BBMRI-ERIC, ELIXIR as well as several NGS-related EU programs to cover all technical aspects and transversal needs & requirements. Driven by patient and clinical needs, innovative NGS workflows from sample-pre-analytics to medical decision making will be developed. The modular design of the workflow will particularly enable SEMs to contribute, and provides flexibility to adopt emerging user needs and technologies. Specifications will address regulatory requirements for IVDs and refer to international standards and requests development of reference materials and implementation of EQA schemes covering the whole workflow. R&D suppliers will be selected based on a public tender all along this PCP process in 3 phases according to the best-value for money solution. The 3 phases foresee the leverage of 4 technical modules (pre-analytics, sequencing, bioinformatics, e-reporting/e-medication) and their standardized interfaces – from design (Phase 1) to prototypes (Phase 2), and full integration in Phase 3. At the end, this PCP will provide 2 fully integrated, standardized NGS workflows for routine diagnostics of common and rare cancers from adults to children. In order to enable broad implementation in healthcare systems throughout Europe and beyond and to increase benefit to patients a series of support activities are planned including communication and dissemination activities targeting a broad stakeholder community, development of training and education material for healthcare professionals and patients, health economic assessment and engagement with healthcare payers and policy makers.


Funded Companies:

Company name Funding amount
Bioxpedia AS €20,678
Centre de Lutte Contre le Cancer Leon Berard €261,257
CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL €0.00
DIN DEUTSCHES INSTITUT FUER NORMUNG e. V. €70,200
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM €315,515
European Cancer Patient Coalition €64,746
Federazione Italiana Delle Associazioni Di Volontariato IN Oncologia €166,590
Fondazione Del Piemonte Per L'Oncologia €0.00
HELSINGIN YLIOPISTO €120,960
HUS-YHTYMA €0.00
Instituto Portugues de Oncologia do Porto Francisco Gentil ΕΠΕ €0.00
Institutul Oncologic Prof DR Ion Chiricuta Cluj-Napoca €0.00
International Prevention Research Institut-Ipri Management €14,988.50
Medizinische Universitat Graz €8,161,113
Organisation OF European Cancer Institutes €82,094
ST. Anna Kinderkrebsforschung GmbH €316,953
ST Anna Kinderkrebsforschung Verein €0.00
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS €0.00
TECHNISCHE UNIVERSITAET MUENCHEN €124,504
The University of Liverpool €152,685
The University of Manchester €100,980
Universita' Degli Studi Di Milano-Bicocca €354,279
Universita Degli Studi Di Firenze €282,295
UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN €266,657
Univerza V Ljubljani €121,635

Source: https://cordis.europa.eu/project/id/874719

The filing refers to a past date, and does not necessarily reflect the current state.

Creative Commons License The visualizations for "Bioxpedia AS - EU funding (€11M): Integrated and standardized NGS workflows for Personalised therapy" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.